POLYMED - IntraDay Trade Analysis with Live Signals

Last Updated Time : 05 Nov 25, 7:43 am

IntraDay Trade Rating: 3.9

📈 POLYMED shows stable momentum and strong fundamentals, but low volume and technical resistance suggest a cautious intraday approach.

📈 Positive

• 📊 MACD at 0.73 and RSI at 52.2 indicate neutral-to-bullish momentum.
• 📈 Price near DMA 50 (₹1,962) and below DMA 200 (₹2,118), offering potential bounce setup.
• 💰 Debt-to-equity ratio of 0.06 reflects strong financial discipline.
• 📈 Quarterly PAT growth of 21.6% shows consistent earnings performance.
• 📈 DII holding increased by 1.81%, signaling domestic institutional confidence.

⚠️ Limitation

• 📉 Volume of 78,926 is below 1-week average of 1.19 lakh, indicating weak intraday participation.
• 📉 P/E of 57.0 vs. industry P/E of 51.3 suggests slight overvaluation.
• 📉 PEG ratio of 1.84 indicates moderate valuation relative to growth.
• 📉 Price has dropped nearly 37% from 52-week high, showing long-term weakness.

🚫 Company Negative News

• 📉 FII holding declined by 1.64%, indicating foreign investor caution.
• 📉 Price trading below DMA 200 may act as resistance for upside moves.

✅ Company Positive News

• 🩺 Strong demand for medical devices and export growth driving revenue stability.
• 📢 Operational efficiency and product innovation continue to support profitability.

🏭 Industry

• 🏥 Industry P/E of 51.3 reflects high growth expectations in healthcare and medical devices.
• 📈 Rising demand for diagnostics and hospital infrastructure supports sector fundamentals.

📌 Conclusion

• ⚠️ POLYMED is a moderate intraday candidate with stable momentum but low volume and technical resistance.
• 💡 Consider buying near ₹1,945–₹1,950 with target at ₹1,975–₹1,985 and stop-loss at ₹1,935.
• 📤 If already holding, exit if price crosses ₹1,980 with volume > 1.2 lakh or RSI > 58.

I can also help you visualize POLYMED’s intraday support and resistance zones for sharper trade execution.